Literature DB >> 10655617

Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.

D R Ronning1, T Klabunde, G S Besra, V D Vissa, J T Belisle, J C Sacchettini.   

Abstract

The antigen 85 (ag85) complex, composed of three proteins (ag85A, B and C), is a major protein component of the Mycobacterium tuberculosis cell wall. Each protein possesses a mycolyltransferase activity required for the biogenesis of trehalose dimycolate (cord factor), a dominant structure necessary for maintaining cell wall integrity. The crystal structure of recombinant ag85C from M. tuberculosis, refined to a resolution of 1.5 A, reveals an alpha/beta-hydrolase polypeptide fold, and a catalytic triad formed by Ser 124, Glu 228 and His 260. ag85C complexed with a covalent inhibitor implicates residues Leu 40 and Met 125 as components of the oxyanion hole. A hydrophobic pocket and tunnel extending 21 A into the core of the protein indicates the location of a probable trehalose monomycolate binding site. Also, a large region of conserved surface residues among ag85A, B and C is a probable site for the interaction of ag85 proteins with human fibronectin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655617     DOI: 10.1038/72413

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  62 in total

1.  Crystal structure of a major secreted protein of Mycobacterium tuberculosis-MPT63 at 1.5-A resolution.

Authors:  Celia W Goulding; Angineh Parseghian; Michael R Sawaya; Duilio Cascio; Marcin I Apostol; Maria Laura Gennaro; David Eisenberg
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

2.  Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.

Authors:  Lanbo Shi; Robert North; Maria Laura Gennaro
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Control of cell wall assembly by a histone-like protein in Mycobacteria.

Authors:  Tomoya Katsube; Sohkichi Matsumoto; Masaki Takatsuka; Megumi Okuyama; Yuriko Ozeki; Mariko Naito; Yukiko Nishiuchi; Nagatoshi Fujiwara; Mamiko Yoshimura; Takafumi Tsuboi; Motomi Torii; Nobuhide Oshitani; Tetsuo Arakawa; Kazuo Kobayashi
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

4.  Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.

Authors:  Albertus Viljoen; Matthias Richard; Phuong Chi Nguyen; Patrick Fourquet; Luc Camoin; Rishi R Paudal; Giri R Gnawali; Christopher D Spilling; Jean-François Cavalier; Stéphane Canaan; Mickael Blaise; Laurent Kremer
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

5.  Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.

Authors:  Lorenza Favrot; Daniel H Lajiness; Donald R Ronning
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

6.  Distribution of sigma factors delineates segregation of virulent and avirulent Mycobacterium.

Authors:  Aayatti Mallick Gupta; Sukhendu Mandal
Journal:  Arch Microbiol       Date:  2021-01-11       Impact factor: 2.552

Review 7.  Current trends in tuberculosis vaccine.

Authors:  J S V Soundarya; Uma Devi Ranganathan; Srikanth P Tripathy
Journal:  Med J Armed Forces India       Date:  2019-01-18

8.  Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex.

Authors:  Chih-Jung Kuo; Christopher P Ptak; Ching-Lin Hsieh; Bruce L Akey; Yung-Fu Chang
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

9.  Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan.

Authors:  Aditya K Sanki; Julie Boucau; Donald R Ronning; Steven J Sucheck
Journal:  Glycoconj J       Date:  2008-12-04       Impact factor: 2.916

10.  T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.

Authors:  Pascal Launois; Annie Drowart; Eliane Bourreau; Pierre Couppie; Claire-Michèle Farber; Jean-Paul Van Vooren; Kris Huygen
Journal:  Clin Dev Immunol       Date:  2010-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.